Is ageing a problematic hurdle to the efficacy of first-line atezolizumab plus bevacizumab in hepatocellular carcinoma?

Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0
제목
Is ageing a problematic hurdle to the efficacy of first-line atezolizumab plus bevacizumab in hepatocellular carcinoma?
저자
An, JihyunShim, Ju H.
DOI
10.1111/liv.15418
발행일
2022-11
유형
Editorial Material
저널명
Liver International
42
11
페이지
2352 ~ 2353